Laboratorios Farmaceuticos (Spain) Buy Hold or Sell Recommendation
| ROVI Stock | EUR 64.45 0.60 0.94% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Laboratorios Farmaceuticos ROVI is 'Strong Sell'. Macroaxis provides Laboratorios Farmaceuticos buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ROVI positions.
Check out Laboratorios Farmaceuticos Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Laboratorios and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Laboratorios Farmaceuticos ROVI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Laboratorios |
Execute Laboratorios Farmaceuticos Buy or Sell Advice
The Laboratorios recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Laboratorios Farmaceuticos ROVI. Macroaxis does not own or have any residual interests in Laboratorios Farmaceuticos ROVI or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Laboratorios Farmaceuticos' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Laboratorios Farmaceuticos Trading Alerts and Improvement Suggestions
| Laboratorios Farmaceuticos generated a negative expected return over the last 90 days | |
| About 60.0% of the company outstanding shares are owned by corporate insiders |
Laboratorios Farmaceuticos Returns Distribution Density
The distribution of Laboratorios Farmaceuticos' historical returns is an attempt to chart the uncertainty of Laboratorios Farmaceuticos' future price movements. The chart of the probability distribution of Laboratorios Farmaceuticos daily returns describes the distribution of returns around its average expected value. We use Laboratorios Farmaceuticos ROVI price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Laboratorios Farmaceuticos returns is essential to provide solid investment advice for Laboratorios Farmaceuticos.
| Mean Return | -0.29 | Value At Risk | -4.34 | Potential Upside | 2.34 | Standard Deviation | 2.36 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Laboratorios Farmaceuticos historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Laboratorios Farmaceuticos Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Laboratorios Farmaceuticos or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Laboratorios Farmaceuticos' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Laboratorios stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | -1.55 | |
σ | Overall volatility | 2.36 | |
Ir | Information ratio | -0.18 |
Laboratorios Farmaceuticos Volatility Alert
Laboratorios Farmaceuticos ROVI exhibits very low volatility with skewness of -2.87 and kurtosis of 13.13. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Laboratorios Farmaceuticos' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Laboratorios Farmaceuticos' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Laboratorios Farmaceuticos Fundamentals Vs Peers
Comparing Laboratorios Farmaceuticos' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Laboratorios Farmaceuticos' direct or indirect competition across all of the common fundamentals between Laboratorios Farmaceuticos and the related equities. This way, we can detect undervalued stocks with similar characteristics as Laboratorios Farmaceuticos or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Laboratorios Farmaceuticos' fundamental indicators could also be used in its relative valuation, which is a method of valuing Laboratorios Farmaceuticos by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Laboratorios Farmaceuticos to competition |
| Fundamentals | Laboratorios Farmaceuticos | Peer Average |
| Return On Equity | 0.39 | -0.31 |
| Return On Asset | 0.18 | -0.14 |
| Profit Margin | 0.23 % | (1.27) % |
| Operating Margin | 0.28 % | (5.51) % |
| Current Valuation | 1.93 B | 16.62 B |
| Shares Outstanding | 51.32 M | 571.82 M |
| Shares Owned By Insiders | 60.25 % | 10.09 % |
| Shares Owned By Institutions | 17.88 % | 39.21 % |
| Price To Earning | 43.87 X | 28.72 X |
| Price To Book | 4.42 X | 9.51 X |
| Price To Sales | 2.54 X | 11.42 X |
| Revenue | 648.68 M | 9.43 B |
| Gross Profit | 379.83 M | 27.38 B |
| EBITDA | 204.66 M | 3.9 B |
| Net Income | 182.63 M | 570.98 M |
| Cash And Equivalents | 126.82 M | 2.7 B |
| Cash Per Share | 2.26 X | 5.01 X |
| Total Debt | 52.52 M | 5.32 B |
| Debt To Equity | 0.18 % | 48.70 % |
| Current Ratio | 2.62 X | 2.16 X |
| Book Value Per Share | 8.28 X | 1.93 K |
| Cash Flow From Operations | 149.44 M | 971.22 M |
| Earnings Per Share | 3.33 X | 3.12 X |
| Price To Earnings To Growth | 3.17 X | 4.89 X |
| Target Price | 68.09 | |
| Number Of Employees | 1.75 K | 18.84 K |
| Beta | 0.47 | -0.15 |
| Market Capitalization | 2.1 B | 19.03 B |
| Total Asset | 732.68 M | 29.47 B |
| Z Score | 23.4 | 8.72 |
| Annual Yield | 0.02 % | |
| Five Year Return | 0.87 % | |
| Net Asset | 732.68 M |
Laboratorios Farmaceuticos Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Laboratorios . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Laboratorios Farmaceuticos Buy or Sell Advice
When is the right time to buy or sell Laboratorios Farmaceuticos ROVI? Buying financial instruments such as Laboratorios Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Laboratorios Farmaceuticos in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run ESG Investing Thematic Idea Now
ESG Investing
Sustainable investments that promote the conservation of the natural world, social resposibility, freindly employees policies and strong governance. The ESG Investing theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ESG Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Laboratorios Stock
Laboratorios Farmaceuticos financial ratios help investors to determine whether Laboratorios Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorios with respect to the benefits of owning Laboratorios Farmaceuticos security.